Characterization of an early dendritic cell precursor derived from murine lineage-negative hematopoietic progenitor cells

被引:24
作者
Jackson, SH
Alicea, C
Owens, JW
Eigsti, CL
Malech, HL
机构
[1] NIAID, NIH, Flow Cytometry Unit, Off Sci Director, Bethesda, MD 20892 USA
[2] NIAID, Host Def Lab, NIH, Bethesda, MD USA
[3] Natl Ctr Res Resources, Vet Pathol Lab, Off Director, NIH, Bethesda, MD USA
关键词
D O I
10.1016/S0301-472X(02)00792-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. We define characteristics of a dendritic cell (DC) precursor generated from murine lineage-negative (Lin(-)) Sca1(+) hematopoietic progenitor cells (HPC). Materials and Methods. Lin(-)Sca1(+) HPC cultured 9 days in 100 ng/mL stem cell factor (SCF), 20 ng/mL interleukin-3 (IL-3), 50 ng/mL monocyte colony-stimulating factor (M-CSF), 5 ng/mL granulocyte-monocyte colony-stimulating factor (GM-CSF), and 25 ng/mL FLT3-ligand (FLT3-L) proliferate 387-fold and differentiate into DC precursors. Switch to greater than or equal to100 ng/mL GM-CSF + 1500 U/mL IL-4 or 500 U/mL tumor necrosis factor-alpha (TNF-alpha) for 3 days induces development into immature DC that are responsive to bacterial lipopolysaccharide (LPS)-induced maturation. Results. Lin(-)Sca1(+) HPC in the first 9 days of culture differentiate into DC precursors expressing surface CD11b(bright), CD11c(mod), CD86(low-mod), major histocompatibility class 11 antigen (MHC) IIlow, DEC 205(low), but are surface CD40(-) and contain high levels of intracellular MHC II Unlike immature DC described by others, these DC precursors are refractory to maturation with LPS and minimally stimulate allogeneic T lymphocytes in mixed leukocyte reactions (MLR). Switch to high-dose GM-CSF alone with IL-4 or TNF-alpha. differentiates these DC precursors into immature DC. LPS treatment of the immature DC results in mature DC that express surface CD40(high) and CD86(high), secrete IL-1beta and IL-12, and strongly stimulate MLR. Conclusions. These studies define a distinct DC precursor derived from murine HPC that precedes development of immature and mature DC. (C) 2002 International Society for Experimental Hematology. Published by Elsevier Science Inc.
引用
收藏
页码:430 / 439
页数:10
相关论文
共 54 条
  • [1] Ahuja SS, 1996, J IMMUNOL, V156, P4345
  • [2] Ahuja SS, 1998, J IMMUNOL, V161, P868
  • [3] Dendritic cells and the control of immunity
    Banchereau, J
    Steinman, RM
    [J]. NATURE, 1998, 392 (6673) : 245 - 252
  • [4] SYNERGISM BETWEEN HEMATOPOIETIC GROWTH-FACTORS (HGFS) DETECTED BY THEIR EFFECTS ON CELLS BEARING RECEPTORS FOR A LINEAGE SPECIFIC HGF - ASSAY OF HEMOPOIETIN-1
    BARTELMEZ, SH
    STANLEY, ER
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1985, 122 (03) : 370 - 378
  • [5] MACROPHAGES SPECIFICALLY REGULATE THE CONCENTRATION OF THEIR OWN GROWTH-FACTOR IN THE CIRCULATION
    BARTOCCI, A
    MASTROGIANNIS, DS
    MIGLIORATI, G
    STOCKERT, RJ
    WOLKOFF, AW
    STANLEY, ER
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (17) : 6179 - 6183
  • [6] A two-step culture method starting with early growth factors permits enhanced production of functional dendritic cells from murine splenocytes
    Berthier, R
    Martinon-Ego, C
    Laharie, AM
    Marche, PN
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 239 (1-2) : 95 - 107
  • [7] Hematologic effects of flt3 ligand in vivo in mice
    Brasel, K
    McKenna, HJ
    Morrissey, PJ
    Charrier, K
    Morris, AE
    Lee, CC
    Williams, DE
    Lyman, SD
    [J]. BLOOD, 1996, 88 (06) : 2004 - 2012
  • [8] Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures
    Brasel, K
    De Smedt, T
    Smith, JL
    Maliszewski, CR
    [J]. BLOOD, 2000, 96 (09) : 3029 - 3039
  • [9] CD34(+) hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha
    Caux, C
    Vanbervliet, B
    Massacrier, C
    DezutterDambuyant, C
    deSaintVis, B
    Jacquet, C
    Yoneda, K
    Imamura, S
    Schmitt, D
    Banchereau, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) : 695 - 706
  • [10] Drakes ML, 1997, J IMMUNOL, V159, P4268